Evan Bloch

Evan Bloch

Johns Hopkins University

H-index: 42

North America-United States

About Evan Bloch

Evan Bloch, With an exceptional h-index of 42 and a recent h-index of 36 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Emerging and neglected infectious diseases, Global blood transfusion safety.

His recent articles reflect a diverse array of research interests and contributions to the field:

Erratum for Gebo et al.,“Early antibody treatment, inflammation, and risk of post-COVID conditions”

New threats from an old foe: Evaluating the risk to the blood supply due to increasing incidence and endemicity of leprosy in the United States

Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload

Human babesiosis

Suspected autoimmune encephalitis: A retrospective study of patients referred for therapeutic plasma exchange

Reevaluation of the medical necessity of washed red blood cell transfusion in chronically transfused adults

The potential association between extracorporeal photopheresis and thrombosis

Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review

Evan Bloch Information

University

Position

Associate Professor of Pathology School of Medicine

Citations(all)

6899

Citations(since 2020)

6041

Cited By

2718

hIndex(all)

42

hIndex(since 2020)

36

i10Index(all)

114

i10Index(since 2020)

107

Email

University Profile Page

Google Scholar

Evan Bloch Skills & Research Interests

Emerging and neglected infectious diseases

Global blood transfusion safety

Top articles of Evan Bloch

Erratum for Gebo et al.,“Early antibody treatment, inflammation, and risk of post-COVID conditions”

Mbio

2024/1/16

New threats from an old foe: Evaluating the risk to the blood supply due to increasing incidence and endemicity of leprosy in the United States

Transfusion and Apheresis Science

2024/1/14

Euvolemic automated transfusion to treat severe anemia in sickle cell disease patients at risk of circulatory overload

Transfusion

2024/1

Human babesiosis

2024/1/1

Robert P Smith
Robert P Smith

H-Index: 8

Evan Bloch
Evan Bloch

H-Index: 24

Suspected autoimmune encephalitis: A retrospective study of patients referred for therapeutic plasma exchange

Journal of Clinical Apheresis

2024/6

Reevaluation of the medical necessity of washed red blood cell transfusion in chronically transfused adults

Transfusion

2024/2

The potential association between extracorporeal photopheresis and thrombosis

Bone marrow transplantation

2024/2

Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review

2024/1/30

Influenza vaccination reveals sex dimorphic imprints of prior mild COVID-19

Nature

2023/2/23

SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations

Nature communications

2023/8/24

Lower anti‐spike levels in B‐cell‐depleted patients after convalescent plasma transfusion suggest the need for repeated doses.

British journal of haematology

2023/1/15

Molecular Screening of Blood Donors for Babesia in Tyrol, Austria

Transfusion Medicine and Hemotherapy

2023/8/2

VIEWPOINTS ARTICLE

2023

Optimizing Blood Transfusion in Patients with Acute Myocardial Infarction

2023/12/28

Advancing blood transfusion safety using molecular detection in the country of Georgia

Transfusion clinique et biologique

2023/8/1

SARS-CoV-2 Seroprevalence Among Ugandan Blood Donors: 2019-2022

Topics in Antiviral Medicine

2023

Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization

Cell Chemical Biology

2023/7/20

401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy

Open Forum Infectious Diseases

2023/12

See List of Professors in Evan Bloch University(Johns Hopkins University)